Antimicrobial polypeptides

Journal of Leukocyte Biology

Volumn 75, Issue 1, 2004, Pages 34-38

  Ganz, Tomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Defensins; Host defense; Innate immunity; Lactoferrin; Lysozyme; Secretory leukoprotease inhibitor

Indexed keywords

ANTIINFECTIVE AGENT; LYSOZYME; POLYPEPTIDE;

ANTIMICROBIAL ACTIVITY; EOSINOPHIL; HOST RESISTANCE; HUMAN; LUNG ALVEOLUS CELL; MACROPHAGE; MONOCYTE; NEUTROPHIL; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY EPITHELIUM; REVIEW; SUBMUCOSA;

ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; MURAMIDASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; RESPIRATORY TRACT DISEASES;

EID: 0842304596     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0403150     Document Type: Review

References (58)

1. Fleming, A. (1922) On a remarkable bacteriolytic element found in tissues and secretions. Proc. R. Soc. Lond. B. Biol. Sci. 93, 306-317.
2. Ganz, T. (2002) Antimicrobial polypeptides in host defense of the respiratory tract. J. Clin. Invest. 109, 693-697.
3. Travis, S. M., Conway, B. A., Zabner, J., Smith, J. J., Anderson, N. N., Singh, P. K., Greenberg, E. P., Welsh, M. J. (1999) Activity of abundant antimicrobials of the human airway. Am. J. Respir. Cell Mol. Biol. 20, 872-879.
4. Cole, A. M., Dewan, P., Ganz, T. (1999) Innate antimicrobial activity of nasal secretions. Infect. Immun. 67, 3267-3275.
5. Cole, A. M., Liao, H. I., Stuchlik, O., Tilan, J., Pohl, J., Ganz, T. (2002) Cationic polypeptides are required for antibacterial activity of human airway fluid. J. Immunol. 169, 6985-6991.
6. Agerberth, B., Grunewald, J., Castanos-Velez, E., Olsson, B., Jornvall, H., Wigzell, H., Eklund, A., Gudmundsson, G. H. (1999) Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med. 160, 283-290.
7. Smith, J. J., Travis, S. M., Greenberg, E. P., Welsh, M. J. (1996) Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229-236.
8. Bals, R., Weiner, D. J., Meegalla, R. L., Wilson, J. M. (1999) Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest. 103, 1113-1117.
9. Raphael, G. D., Jeney, E. V., Baraniuk, J. N., Kim, I., Meredith, S. D., Kaliner, M. A. (1989) Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions. J. Clin. Invest. 84, 1528-1535.
10. Brogan, T. D., Ryley, H. C., Neale, L., Yassa, J. (1975) Soluble proteins of bronchopulmonary secretions from patients with cystic fibrosis, asthma, and bronchitis. Thorax 30, 72-79.
11. Harbitz, O., Jenssen, A. O., Smidsrod, O. (1984) Lysozyme and lactoferrin in sputum from patients with chronic obstructive lung disease. Eur. J. Respir. Dis. 65, 512-520.
12. Kotlar, H. K., Harbitz, O., Jenssen, A. O., Smidsrod, O. (1980) Quantitation of proteins in sputum from patients with chronic obstructive lung disease. II. Determination of albumin, transferrin, alpha1-acid glycoprotein, IgG, IgM, lysozyme and C3-complement factor. Eur. J. Respir. Dis. 61, 233-239.
13. Thompson, A. B., Bohling, T., Payvandi, F., Rennard, S. I. (1990) Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J. Lab. Clin. Med. 115, 148-158.
14. Rennard, S. I., Basset, G., Lecossier, D., O'Donnell, K. M., Pinkston, P., Martin, P. G., Crystal, R. G. (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Physiol. 60, 532-538.
15. Hill, A. T., Bayley, D. L., Campbell, E. J., Hill, S. L., Stockley, R. A. (2000) Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. Eur. Respir. J. 15, 886-890.
16. Lee, C. H., Igarashi, Y., Hohman, R. J., Kaulbach, H., White, M. V., Kaliner, M. A. (1993) Distribution of secretory leukoprotease inhibitor in the human nasal airway. Am. Rev. Respir. Dis. 147, 710-716.
17. Soong, L. B., Ganz, T., Ellison, A., Caughey, G. H. (1997) Purification and characterization of defensins from cystic fibrosis sputum. Inflamm. Res. 46, 98-102.
18. Schnapp, D., Harris, A. (1998) Antibacterial peptides in bronchoalveolar lavage fluid. Am. J. Respir. Cell Mol. Biol. 19, 352-356.
19. Singh, P. K., Jia, H. P., Wiles, K., Hesselberth, J., Liu, L., Conway, B. D., Greenberg, E. P., Valore, E. V., Welsh, M. J., Ganz, T., et al. (1998) Production of β-defensins by human airway epithelia. Proc. Natl. Acad. Sci. USA 95, 14961-14966.
20. Bals, R., Wang, X., Zasloff, M., Wilson, J. M. (1998) The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95, 9541-9546.
21. Becker, M. N., Diamond, G., Verghese, M. W., Randell, S. H. (2000) CD14-dependent lipopolysaccharide-induced beta -defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem. 275, 29731-29736.
22. Laible, N. J., Germaine, G. R. (1985) Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect. Immun. 48, 720-728.
23. Ellison, R. T., Giehl, T. J. (1991) Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88, 1080-1091.
24. Akinbi, H. T., Epaud, R., Bhatt, H., Weaver, T. E. (2000) Bacterial killing is enhanced by expression of lysozyme in the lungs of transgenic mice. J. Immunol. 165, 5760-5766.
25. Ganz, T., Gabayan, V., Liao, H. I., Liu, L., Oren, A., Graf, T., Cole, A. M. (2003) Increased inflammation in lysozyme M-deficient mice in response to Micrococcus luteus and its peptidoglycan. Blood 101, 2388.
26. Arnold, R. R., Cole, M. F., McGhee, J. R. (1977) A bactericidal effect for human lactoferrin. Science 197, 263-265.
27. Arnold, R. R., Russell, J. E., Champion, W. J., Brewer, M., Gauthier, J. J. (1982) Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect. Immun. 35, 792-799.
28. Hiemstra, P. S., Maassen, R. J., Stolk, J., Heinzel-Wieland, R., Steffens, G. J., Dijkman, J. H. (1996) Antibacterial activity of antileukoprotease. Infect. Immun. 64, 4520-4524.
29. Zhu, J., Nathan, C., Ding, A. (1999) Suppression of macrophage responses to bacterial lipopolysaccharide by a non-secretory form of secretory leukocyte protease inhibitor. Biochim. Biophys. Acta 1451, 219-223.
30. Lehrer, R. I., Lichtenstein, A. K., Ganz, T. (1993) Defensins: Antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11, 105-128.
31. Jones, D. E., Bevins, C. L. (1992) Paneth cells of the human small intestine express an antimicrobial peptide gene. J. Biol. Chem. 267, 23216-23225.
32. Jones, D. E., Bevins, C. L. (1993) Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett. 315, 187-192.
33. Bensch, K. W., Raida, M., Magert, H. J., Schulz-Knappe, P., Forssmann, W. G. (1995) hBD-1: A novel beta-defensin from human plasma. FEBS Lett. 368, 331-335.
34. Valore, E. V., Park, C. H., Quayle, A. J., Wiles, K. R., McCray, P. B., Ganz, T. (1998) Human beta-defensin-1: An antimicrobial peptide of urogenital tissues. J. Clin. Invest. 101, 1633-1642.
35. Harder, J., Bartels, J., Christophers, E., Schroeder, J.-M. (1997) A peptide antibiotic from human skin. Nature 387, 861-862.
36. Jia, H. P., Schutte, B. C., Schudy, A., Linzmeier, R., Guthmiller, J. M., Johnson, G. K., Tack, B. F., Mitros, J. P., Rosenthal, A., Ganz, T., et al. (2001) Discovery of new human beta-defensins using a genomics-based approach. Gene 263, 211-218.
37. Harder, J., Bartels, J., Christophers, E., Schroder, J. M. (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276, 5707-5713.
38. Garcia, J. R., Jaumann, F., Schulz, S., Krause, A., Rodriguez-Jimenez, J., Forssmann, U., Adermann, K., Kluver, E., Vogelmeier, C., Becker, D., et al. (2001) Identification of a novel, multifunctional beta-defensin (human beta- defensin 3) with specific antimicrobial activityIts interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306, 257-264.
39. Garcia, J. R., Krause, A., Schulz, S., Rodriguez-Jimenez, F. J., Kluver, E., Adermann, K., Forssmann, U., Frimpong-Boateng, A., Bals, R., Forssmann, W. G. (2001) Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 15, 1819-1821.
40. Zhao, C. Q., Wang, I., Lehrer, R. I. (1996) Widespread expression of beta-defensin HBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396, 319-322.
41. Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V., Zasloff, M., Wilson, J. M. (1998) Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Invest. 102, 874-880.
42. Diamond, G., Russell, J. P., Bevins, C. L. (1996) Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc. Natl. Acad. Sci. USA 93, 5156-5160.
43. Ayabe, T., Satchell, D. P., Wilson, C. L., Parks, W. C., Selsted, M. E., Ouellette, A. J. (2000) Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1, 113-118.
44. Ganz, T., Lehrer, R. I. (1995) Defensins. Pharmacol. Ther. 66, 191-205.
45. Van Wetering, S., Mannesse-Lazeroms, S. P., van Sterkenburg, M. A., Daha, M. R., Dijkman, J. H., Hiemstra, P. S. (1997) Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am. J. Physiol. 272, L888-L896.
46. Van Wetering, S., Der Linden, A. C., van Sterkenburg, M. A., de Boer, W. I., Kuijpers, A. L., Schalkwijk, J., Hiemstra, P. S. (2000) Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L51-L58.
47. Yang, D., Chertov, 0., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schroder, J. M., Wang, J. M., Howard, O. M., et al. (1999) Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286, 525-528 (see comments).
48. Ganz, T. (1999) Defensins and host defense. Science 286, 420-421 (comment).
49. Zanetti, M., Gennaro, R., Romeo, D. (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374, 1-5.
50. Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., Wright, S. C. (1995) Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63, 1291-1297.
51. Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., Salcedo, R. (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238, 325-332.
52. Sorensen, O., Amljots, K., Cowland, J. B., Bainton, D. F., Borregaard, N. (1997) The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90, 2796-2803.
53. Frohm, M., Agerberth, B., Ahangari, G., Stahle-Backdahl, M., Liden, S., Wigzell, H., Gudmundsson, G. H. (1997) The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272, 15258-15263.
54. Frohm, N. M., Sandstedt, B., Sorensen, O., Weber, G., Borregaard, N., Stahle-Backdahl, M. (1999) The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67, 2561-2566.
55. Turner, J., Cho, Y., Dinh, N. N., Waring, A. J., Lehrer, R. I. (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206-2214.
56. Ganz, T., Bellm, L., Lehrer, R. I. (2000) Protegrins: new antibiotics of mammalian origin. Expert Opin. Investig. Drugs 9, 1731-1742.
57. Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., Wilson, J. M. (1999) Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 67, 6084-6089.
58. Cole, A. M., Shi, J., Ceccarelli, A., Kim, Y. H., Park, A., Ganz, T. (2001) Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97, 297-304.